Generally, PLA2R1 promoter methylation was found to be strongly elevated at diagnosis in BM and PB samples but decreased rapidly during ALL induction treatment mostly falling below the methylation degree of healthy controls. Here, PLA2R1 is linked to acute lymphoblastic leukemia.